New TCR-T Therapy Afami-cel For Advanced Sarcoma With Promising And Long-Lasting Results!
"New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial
Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers
Keio University Hospital
Cutting-Edge Targeted Drug For Cholangiocarcinoma Significantly Extends Patients' Lives!
It is easy to suffer from cerebral apoplexy, chronic bronchitis and skin itching in autumn and winter. How to prevent
